Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

标题
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
作者
关键词
Pancreatic cancer, FOLFIRINOX, Gemcitabine/nab-paclitaxel, First-line treatment, Real-world, Propensity score
出版物
EUROPEAN JOURNAL OF CANCER
Volume 151, Issue -, Pages 3-13
出版商
Elsevier BV
发表日期
2021-05-02
DOI
10.1016/j.ejca.2021.03.040

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started